It’s a new era for Clinipace.  Jason Monteleone, the new CEO says Clinipace will be focused on building out a number of therapeutic areas as well as its regulatory business in the remainder of 2017 and next year.

Growing the therapeutic areas of oncology, gastroenterology and nephrology will be of particular focus for Clinipace moving forward, as will be growing the company’s regulatory consulting business, which Monteleone calls a “hidden gem inside the organization.”



Back to News